PFE  Pfizer Inc.

Exchange

NYSE

Sector

Consumer Durables

Industry

Major Pharmaceuticals

Market Cap.

222.16B

Vuru Grade

60.55/100

Current Price

$36.63
-0.22 (-0.60%)

Growth Price

$25.70
Overvalued by 29.83%

Stability Price

$11.98
Overvalued by 67.28%

Company Metrics

  • P/E 30.02
  • P/S 4.38
  • P/B 3.54
  • EPS 1.22
  • Cash ROIC 13.13%
  • Cash Ratio 0.79
  • Dividend 1.2 / 3.26%
  • Avg. Vol. 24.87M
  • Shares 6.06B
  • Market Cap. 222.16B

Company Description

Pfizer Inc., a biopharmaceutical company, offers prescription medicines for humans and animals worldwide. The company's Biopharmaceutical segment's provides Lipitor for elevated LDL-cholesterol levels in the blood; Enbrel for rheumatoid arthritis, polyarticular juvenile rheumatoid arthritis, psoriatic arthritis, plaque psoriasis, and ankylosing spondylitis; Lyrica for post-herpetic neuralgia, diab... more


Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow

News

Is Pfizer Stock A Buy Going Into The Q2 Earnings?
Amigobulls - Jul 27, 2016
Pfizer (NYSE:PFE) announces its second quarter earnings on the 2nd of August and the average EPS estimate is $0.62 per share.
What Wall Street is saying about Pfizer Inc. (NYSE:PFE)
Zergwatch - Jul 27, 2016
Pfizer Inc. (NYSE:PFE) stock is currently trading at about $36.83 and lots of rating firms seem to have a target price set on the stock.
Raiff Partners INC Decreased Stake in Pfizer INC (NYSE:PFE) by $3.05 Million ... - Press Telegraph
Pfizer Inc. (NYSE:PFE) Upcoming Earnings: What matter for investors? - The Voice Registrar
Pfizer And Western Oncolytics Reach Immuno-Oncology Research Collaboration
Benzinga - 9 hours ago
Pfizer Inc. (NYSE: PFE) and Western Oncolytics disclosed Thursday that they struck a development collaboration, license and option agreemen.
Pfizer Inc.: Pfizer and Western Oncolytics Announce Immuno-Oncology Research ... - The Wall Street Transcript
Pfizer (PFE) Stock Down, Partners with Western Oncolytics on Cancer Technology - TheStreet.com
Earnings Estimates Analysis: Pfizer Inc. (NYSE:PFE)
News Oracle - 9 hours ago
The Company gained 0.05% and finished at $36.85. The daily volume was measured at 14.98 million shares. The 52-week high of the share price is $37.19 and the 52-week low is $28.25.
Recent Analysts Rating Overview: Pfizer, Inc. (NYSE:PFE) , Endo International ...
Street Updates - 11 hours ago
Recent Analysts Rating Overview: Pfizer, Inc. (NYSE:PFE) , Endo International plc (NASDAQ:ENDP) - The following two tabs change content below.
Broker Outlook For Pfizer, Inc. (NYSE:PFE) - Fiscal Standard
Trading Action Recap: Active Stock Watch for Pfizer Inc. (NYSE:PFE) - TGP
Pfizer Inc (NYSE:PFE) nearing 52-week high, short interest decreasing
Street Report - Jul 26, 2016
Pfizer Inc (NYSE:PFE) (Trend Analysis) shares were traded with thin volume. The stock closed last trading session at $36.78, up by 0.11%, with a volume of 12,175,264 shares against an average amount for the last three months of 25,506,000.
1832 Asset Management L.P. Acquires 1226292 Shares of Pfizer Inc. (PFE) - The Cerbat Gem
Pfizer Inc. (NYSE:PFE) Analyst Research Summary - Zergwatch
Pfizer Inc. (NYSE:PFE) added about 12 percent in value since last earnings
Zergwatch - Jul 26, 2016
Pfizer Inc. (NYSE:PFE) is expected to announce second quarter financial results before market open (confirmed) on August 02, 2016.
Pfizer Inc. (PFE) Closes 0.05% Up on the Day for July 27
Equities.com - Jul 27, 2016
Dow Jones component Pfizer Inc. (PFE) saw its stock move 0.05% to $36.85, representing a per-share move of $0.02, on volume of 14.96 million shares for Wednesday.
Analysts Watching Stocks: Pfizer, Inc. (NYSE:PFE) , ACADIA Pharmaceuticals Inc ...
Street Updates - Jul 27, 2016
Pfizer, Inc. (NYSE:PFE) accumulated +0.14%, closing at $36.83 after floating between $36.65 and $36.87. The company has market capitalization of $223.37B.
Credit Agricole S A Reduces Stake in Pfizer Inc. (PFE)
The Cerbat Gem - Jul 24, 2016
Pfizer logo Credit Agricole S A decreased its position in Pfizer Inc. (NYSE:PFE) by 12.5% during the first quarter, according to its most recent disclosure with the SEC.
NWQ Investment Management Company LLC Has $74651000 Stake in Pfizer Inc. (PFE) - Community Financial News
Were Analysts Bullish Pfizer Inc. (NYSE:PFE) This Week? - Consumer Eagle